Weston Daniel, PhD

Weston Daniel, PhD has a diverse and extensive work experience. Weston is currently the Chief Development Officer (CDO) at EVOQ Therapeutics since April 2023. Prior to that, they held various roles at Exicure from 2010 to 2023, starting as a Research Scientist and progressing to Director Program Management and then Senior Director Program Management. As the Vice President of Translational Research at Exicure, Weston Daniel was responsible for developing and leading the execution of translational, regulatory, and clinical development strategies. Weston presented to and negotiated with global health regulators and promoted the company's platform technology and development programs to potential corporate partners, analysts, and the investor community. Additionally, they played a key role in winning over $1.97 million in grants as a Laboratory Director at Exicure. Weston Daniel's academic background includes being a Graduate Student at Northwestern University from 2006 to 2010.

Weston Daniel, PhD began their education at the University of Minnesota from 2002 to 2005, where they obtained their Bachelor of Science in Chemistry. Weston then pursued further studies at Northwestern University from 2006 to 2010, earning their PhD in Chemistry.